Shiozawa, M., Sunakawa, Y., Watanabe, T., Ota, H., Yasui, H., Yabuno, T., . . . Tsuji, A. Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: A randomized phase II DEEPER trial. Nature Portfolio.
Chicago Style (17th ed.) CitationShiozawa, Manabu, et al. Modified FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS Wild-type Metastatic Colorectal Cancer: A Randomized Phase II DEEPER Trial. Nature Portfolio.
MLA (9th ed.) CitationShiozawa, Manabu, et al. Modified FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS Wild-type Metastatic Colorectal Cancer: A Randomized Phase II DEEPER Trial. Nature Portfolio.
Warning: These citations may not always be 100% accurate.